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Native OCT4 protein has the intrinsic ability of crossing cellular membranes to enter cells. This finding could revive
efforts to induce pluripotency with proteins replacing nucleic acid-based approaches, and raises the intriguing
question as to whether OCT4 can act non-cell-autonomously.
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The octamer binding protein 4 (OCT4) is one of the
prominent transcription factor proteins that featured
in Yamanaka’s original four factor-cocktail (OCT4,
SOX2, KLF4 and c-MYC). This combination of tran-
scription factors is capable of inducing the reprogram-
ming of somatic cells into induced pluripotent stem cells
(iPSCs) in mouse and human [1]. OCT4 is also present
in many alternative cocktails achieving a similar feat [2]
and, when brought into certain cell types, is able to in-
duce pluripotency alone without the help of additional
factors [3]. Initially, reprogramming factors were intro-
duced into cells using retroviral vectors that integrate
into the genome with the side effect of causing poten-
tially harmful mutations to the host [4]. Clearly, such
genetic alterations should be avoided if cells derived
from such procedures are to be used in clinical applica-
tions. Consequently, various studies have focused on the
derivation of iPSCs that obviate genomic integration. For
example, episomal vectors containing six reprogram-
ming factors (OCT4, SOX2, NANOG, LIN28, KLF4 and
c-MYC) are now commonly used [5]. Likewise, adenoviral
vectors [6,7] and non-integrating DNA based plasmids
[8,9] were explored as non-integrating reprogramming
strategies. Moreover, the use of modified RNAs consti-
tuted a further step towards the generation of safe and
genetically unscathed iPSCs [10]. However, at least some
of the nucleic acid based reprogramming strategies carry
residual risks of modifying the host’s genome, also present
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article, unless otherwise stated.time cannot easily be controlled [4]. Collectively, those
caveats could hamper regulatory approval of therapeutic
cells derived from nucleic acid based reprogramming
strategies. The search for alternative iPSC generation
strategies that avoid nucleic acids altogether has therefore
continued. The next logical step after using DNA and
RNA based delivery of reprogramming factors was the
usage of cell penetrating versions of the four proteins
themselves. Indeed, protein-induced pluripotent stem cells
(piPSCs) could be generated by using recombinant pro-
teins expressed in E. coli supplemented with valproic acid
[11], recombinant proteins from crude HEK293 cell ex-
tract [12] or from total embryonic stem cell (ESC) extract
[13]. piPSCs generation normally relies on tags to facilitate
cell permeation such as poly-arginine (9 arginines [12] or
11 arginines [11]) or an equally highly basic 12 amino
acids peptide derived from the human immunodeficiency
virus type 1 (HIV-1) Tat protein (TAT) [14]. However,
since proteins derived from crude cellular extracts of ESCs
could support piPSCs formation, the addition of such
fusion tags may not be essential [13]. Disappointingly
though, the efficiency of protein induced reprogramming
is very low and, therefore, piPSCs have not become popu-
lar until recently. In this regard, the discovery that the ac-
tivation of innate immunity could profoundly improve the
production of piPSCs could be a game changer and push
the approach to center stage [15].
The findings reported by Harreither et al. in a recent
issue of Cell Regeneration [16] could further boost the
popularity of piPSCs. Rather than attaching a cell pene-
trating peptide (CPP) tag that was previously deemed
necessary when piPSCs were generated with recombin-
ant proteins, the authors wondered if the OCT4 protein
could enter cells without modifications. Several othertral Ltd. This is an Open Access article distributed under the terms of the
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trate the membrane barriers of the cell. Amongst them
is the well-known CPP penetratin derived from the
homeodomain of Antennapedia. Coincidentally, OCT4
contains a bi-partite POU domain to bind DNA con-
sisting of a POU specific and a POU homeodomain.
Harreither et al. realized that a 16-amino-acid peptide
derived from the third helix of the homeodomain of
OCT4 has 68% amino acid similarity with penetratin
and hypothesized that it would translocate into living
cells thereby functioning as a CPP. Indeed, the OCT4
peptide N-terminally labeled with fluorescein isothio-
cyanate (FITC) could enter cells within 1 hour, suggest-
ing uptake efficiency even higher than that of the
penetratin control. Further experiments suggested that
the penetration occurs via the endocytic pathway. En-
couragingly, the OCT4-CPP did not appear to get stuck
in endosomes but was found homogenously throughout
the cytoplasm and even within the nucleus. Moreover,
the OCT4-CPP can be used as vehicle to support the
translocation of otherwise non-penetrating cargo pro-
teins. For example, OCT4-CPP-Cre fusion protein could
readily enter CVI-5B cells containing a loxP-modified
reporter system. However, the CPP activity was found to
be weaker than other typical CPPs such as TAT. The
next obvious question was whether the new CPP could
support cellular entry of the unmodified full length
OCT4 protein. To test this, the authors used human
OCT4 purified from E. coli inclusion bodies and incu-
bated it with CVI-5B cells and human BJ foreskinFigure 1 The third helix of the human OCT4 protein contains a cell p
somatic cells. Potentially, native (or truncated) OCT4 can be used to gene
small molecules [22] or other cell-penetrating factors and activators of the
raw materials to produce clinical grade cells for safe cell therapy.fibroblasts at a concentration of 100 nM. Immunostain-
ing revealed that the OCT4 protein penetrated both cell
types, suggesting that the unmodified OCT4 protein can
be used as self-penetrating pluripotency reprogramming
factor without the addition of cationic fusion tag.
The use of recombinant proteins for cellular repro-
gramming would eliminate the risks of nucleic acid
based approaches and could prove to be a versatile way
to generate iPSCs. Notably, a truncated version of the
transcription factor Nanog consisting of only the 70
amino acid homedomain retains the capacity to promote
reprogramming [17]. Similarly, versions of Sox proteins
trimmed to their DNA binding high mobility group
(HMG) domain still support reprogramming when a
VP16 transactivation domain is added [18]. Collectively,
one might thus envisage cocktails of reprogramming
factors, truncated and/or enhanced with transactiva-
tion domains and CPPs [19], that readily cross cellular
membranes and promote reprogramming (Figure 1).
Previously, poor delivery, the cumbersome production
of recombinant proteins and low reprogramming effi-
ciency has hampered the widespread use of piPSCs.
Yet, self-penetrating proteins (e.g. OCT4) and trun-
cated proteins might be more readily available and un-
leash a renaissance of the piPSCs technology. Clearly,
proteins could allow for more accurate dosing, highly
defined timing of factor exposure and maximal control
over the sequence of factor addition not easily possible
with other techniques. Controllability is very desirable,
since both the efficiency [20] as well as the outcomeenetrating peptide (orange) enabling the native protein to enter
rate integration-free piPSCs in combination with other factors such as
innate immunity [15] (indicated as ‘X’ in the figure) that can serve as
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quence of factor addition. The recently reported pro-
duction of chemically induced pluripotent stem cells
(CiPSCs) that relied solely on a combination of 7 small-
molecule compounds [22] is another promising alternative
to standard reprogramming approaches, but still awaits
widespread acceptance in the field.
Besides its practical implications for reprogramming
purposes, the present work also raises some intriguing
mechanistic questions. Some homeodomain transcrip-
tion factors were found to jump from cell to cell on an
organismic level. For example, Otx2 can function non-
cell-autonomously by transferring from the retina to the
visual cortex where it contributes to neurophysiological
responses triggered by visual experiences [23]. Is OCT4
also able to execute gene expression programs in blasto-
cyst cells where its gene is actually silenced because the
OCT4 protein is taken up by a paracrine signaling
mechanism? If true, this would imply that cell penetra-
tion is a two-way street and OCT4 is secreted and taken
up with similar efficiency.
In summary, the study by Harreither et al. emphasizes
that piPSCs are still in the race. To date, the jury is still
out on which approach will be most effective, tunable
and safe to produce clinical grade iPSCs.
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